Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Goettingen – page 23

322 clinical trials in Goettingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Goettingen at a glance
322
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

322 trials in Goettingen

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen - Cilag International
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Avapritinib
  • Sponsor:Blueprint Medicines Corp.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Betula Pollen Extract
  • Sponsor:Stallergenes
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Merck Sharp & Dohme LLC
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone Sodium Phosphate
  • Sponsor:Rheinische Friedrich-Wilhelms-Universitaet Bonn
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Vidofludimus Calcium
  • Sponsor:Goethe University Frankfurt
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Amgen Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Asthma

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Tiotropium Bromide Monohydrate
  • Sponsor:Goethe University Frankfurt
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Goettingen

What the registry says about research in the country

01 Neurological & Brain Disorders

Innovative research focusing on acute cerebral ischemic stroke treatment and groundbreaking studies in Alzheimer's Disease management, evaluating novel therapeutic approaches for improving patient outcomes.

  • Stroke treatment evaluation
  • Cognitive function improvement
  • Neurological recovery assessment

Clinical trials examining the safety and efficacy of targeted therapies for acute neurological conditions.

02 Oncology Research

Comprehensive studies in various cancer types, including lymphoma and lung cancer, with particular focus on targeted therapies and innovative treatment combinations.

  • Blood cancer treatments
  • Advanced NSCLC therapy
  • Colorectal cancer interventions

Evaluating novel therapeutic approaches for both rare and common cancer types.

03 Ophthalmologic Conditions

Advanced research in eye disorders, particularly focusing on thyroid eye disease and geographic atrophy, exploring new treatment modalities and therapeutic antibodies.

  • Vision preservation therapies
  • Age-related eye conditions
  • Inflammatory eye disorders

Investigating breakthrough treatments for both rare and common eye conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.